查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1612174

獸用抗生素和抗菌藥物市場：依產品、給藥方式、形式和動物類型 - 2025-2030年全球預測

Animal Antibiotics & Antimicrobials Market by Product (Antibiotics, Antimicrobial), Mode of Delivery (Injections, Oral), Form, Type of Animal - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年獸用抗生素及抗菌藥物市值為6.3551億美元，預計2024年將達到6.6723億美元，複合年成長率為5.25%，2030年將達9億美元，預計將達到984萬美元。

獸用抗生素和抗菌藥物市場的定義是專門針對動物微生物感染的預防和治療的產品，從而確保動物健康並提高牲畜的糧食生產生產力。由於動物族群中疾病傳播的風險不斷增加、提高生長速度和飼料效率的需求以及全球對動物性食品的需求不斷增加，因此需要這個市場。應用範圍涵蓋獸醫、牲畜管理、寵物護理和水產養殖，最終用戶包括農民、獸醫和製藥商。人們對動物健康問題的認知不斷提高、獸醫學的進步以及全球肉類消費的擴大推動了市場的成長。然而，新興國家也存在著巨大的商機，特別是在亞太地區和南美洲，這些國家的畜牧業隨著都市化而不斷擴張。影響成長的關鍵因素包括抗菌藥物和替代產品的創新、鼓勵減少抗生素使用的法律規範以及增加對獸醫保健的投資。相反，市場成長面臨嚴格監管、對抗生素抗藥性日益擔憂以及對無抗生素和有機農業日益支持等挑戰。透過分子診斷和精準醫學進行的個人化治療創新，以及益生菌和草藥抗菌劑等替代產品的開發，為業務擴張提供了潛力。市場性質的趨勢揭示了綜合健康管理解決方案的趨勢，該解決方案涉及整個食品供應鏈的協作，以確保永續性和合規性。回應監管變化，投資新的永續產品的研發，並加強與動物用藥品整體相關人員的策略夥伴關係，以最佳化成長潛力，同時克服市場挑戰。總體而言，展望強調推進動物用藥品健康解決方案和減輕與抗菌素抗藥性相關的公共衛生問題之間的平衡。

主要市場統計
基準年[2023] 63551萬美元
預計年份 [2024] 66723萬美元
預測年份 [2030] 9.0984億美元
複合年成長率（%） 5.25%

市場動態：快速發展的獸用抗生素和抗菌素市場的關鍵市場洞察

供需的動態交互作用正在改變獸用抗生素和抗菌藥物市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 畜產量需求增加，青黴素類抗生素需求旺盛
    • 政府加強對牲畜傳染病控制的參與
    • 動物疾病治療開發的資本投入大幅增加
  • 市場限制因素
    • 對抗生素抗藥性的擔憂、嚴格的監管核准
  • 市場機會
    • 最先進的研發設施並加速開發新藥活動
    • 人們越來越關注新型抗菌藥物的永續性
  • 市場問題
    • 替代品的可用性

波特五力：駕馭獸用抗生素和抗菌藥物市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架描述了評估公司競爭和探索策略機會的清晰方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢、解決弱點並避免潛在的挑戰，以確保更強大的市場地位。

PESTLE分析：了解外部對獸用抗生素和抗菌藥物市場的影響

外部宏觀環境因素對獸用抗生素和抗菌藥物市場的表現動態起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析：了解獸用抗生素及抗菌藥物市場競爭狀況

獸用抗生素和抗菌藥物市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、細分和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣：獸用抗生素和抗菌藥物市場供應商的績效評估

FPNV定位矩陣是評估獸用抗生素和抗菌藥物市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議：規劃獸用抗生素和抗生素市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對獸用抗生素和抗菌藥物市場進行策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

該報告對涵蓋關鍵焦點細分市場的市場進行了全面分析。

1.市場滲透率：對當前市場環境的詳細審查，主要企業的廣泛資料，評估他們在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有細分市場的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策。

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品和地區提供最佳投資機會？

3.塑造市場的關鍵技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 畜產品和青黴素抗生素的需求增加
      • 加強政府參與對抗動物疾病爆發
      • 動物疾病治療方法研發的資本投入大幅增加
    • 抑制因素
      • 對抗生素抗藥性的擔憂 嚴格的監管核准
    • 機會
      • 加速先進的研發設施和開發新藥活動
      • 更加關注新型抗菌藥物的永續性
    • 任務
      • 替代品的可用性
  • 市場區隔分析
    • 產品：疾病預防和治療對抗生素的需求不斷成長
    • 給藥方法：由於它是一種非侵入性操作，因此口服給藥的趨勢不斷增加。
    • 形式：增加使用抗菌溶液來治療嚴重細菌感染疾病的個別動物
    • 動物類型：寵物對抗生素和抗菌藥物的需求不斷成長，以控制細菌感染
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 經濟
    • 社會
    • 科技
    • 法律
    • 環境

第6章獸用抗生素/抗生素市場：依產品

  • 介紹
  • 抗生素
  • 抗菌的

第7章 獸用抗生素/抗生素市場：依管理方式分類

  • 介紹
  • 注射
  • 口服

第8章獸用抗生素/抗生素市場：依形式

  • 介紹
  • 粉末和錠劑
  • 解決方案

第9章獸用抗生素/抗生素市場：依動物類型

  • 介紹
  • 伴同性動物
    • 貓
    • 狗
    • 馬
  • 食用動物
    • 牛
    • 豬
    • 家禽
    • 綿羊和山羊

第10章：美洲獸用抗生素和抗菌藥物市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太獸用抗生素和抗菌藥物市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲獸用抗生素及抗菌藥物市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Zoetis 在美國商業推出 Librera（維丁貝托單抗注射液），展現了狗狗的創新
    • Huvepharma 將唯一經 FDA核准的三重磺胺藥物返回美國市場
    • Elanco 和 Ginkgo Bioworks 推出 BiomEdit，這是一家利用微生物組技術的新動物保健公司
  • 戰略分析和建議

公司名單

  • American Regent Inc.
  • Ayurvet
  • Bayer AG
  • Boehringer Ingelheim GmbH
  • Ceva Sante Animale
  • Chanelle Pharma
  • Dechra Pharmaceuticals PLC
  • Eco Animal Health Group PLC
  • Elanco Animal Health Incorporated
  • Eli Lilly and Company
  • Endovac Animal Health, LLC
  • Hester Biosciences Limited
  • Hipra Laboratories, SA
  • Inovet Group
  • Neogen Corporation
  • Norbrook Laboratories Ltd.
  • Novartis AG
  • Phibro Animal Health Corporation
  • Sanofi-Aventis Groupe SA
  • Tianjin Ringpu BIoTechnology Co., Ltd.
  • Vetoquinol SA
  • Virbac SA
  • Zoetis, Inc.
  • Zydus Pharmaceuticals, Inc.
Product Code: MRR-031BF22F949D

The Animal Antibiotics & Antimicrobials Market was valued at USD 635.51 million in 2023, expected to reach USD 667.23 million in 2024, and is projected to grow at a CAGR of 5.25%, to USD 909.84 million by 2030.

The Animal Antibiotics & Antimicrobials market is defined by products explicitly aimed at preventing and treating microbial infections in animals, thus securing animal health and improving productivity in livestock for food production. This market is necessitated by the heightened risk of disease spread in animal populations, the need to enhance growth rates and feed efficiency, and an increasing global demand for animal-derived food products. Its application spans across veterinary medicine, livestock management, pet care, and aquaculture, with end-users ranging from farmers and veterinarians to pharmaceutical manufacturers. Market growth is driven by rising awareness of animal health issues, advancements in veterinary medicine, and growing global meat consumption. However, significant opportunities lie in emerging economies where livestock industries are concurrently expanding with urbanization, particularly in Asia-Pacific and South America. Key influencing growth factors include technological innovation in antimicrobial and alternative products, regulatory frameworks encouraging reduced antibiotic use, and increased investment in veterinary healthcare. Conversely, market growth faces challenges such as stringent regulations, rising antibiotic resistance concerns, and growing advocacy for antibiotic-free and organic farming. Innovations in molecular diagnostics and precision medicine for tailored treatment, coupled with the development of alternative products such as probiotics and herbal antimicrobials, present potential areas for business expansion. Insights into the market nature reveal a trend towards integrated health management solutions involving collaboration across the food supply chain to ensure sustainability and compliance. Adapting to regulatory changes, investing in R&D for novel and sustainable products, and enhancing strategic partnerships with stakeholders across the animal health spectrum are recommended strategies to navigate market challenges while optimizing growth potential. Overall, the future outlook underscores a balance between advancing animal health solutions and mitigating public health concerns related to antimicrobial resistance.

KEY MARKET STATISTICS
Base Year [2023] USD 635.51 million
Estimated Year [2024] USD 667.23 million
Forecast Year [2030] USD 909.84 million
CAGR (%) 5.25%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Animal Antibiotics & Antimicrobials Market

The Animal Antibiotics & Antimicrobials Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising demand for livestock products and strong demand for penicillin based antibiotics
    • Increasing government involvement in countering animal diseases outbreaks
    • Growing huge capital investment for the development of drugs for animal diseases
  • Market Restraints
    • Concerns regarding resistance to antibiotic stringent regulatory approvals
  • Market Opportunities
    • Accelerating advanced research and development facilities, and new drug development activities
    • Growing focus towards sustainability of new antimicrobials
  • Market Challenges
    • Availability of substitutes

Porter's Five Forces: A Strategic Tool for Navigating the Animal Antibiotics & Antimicrobials Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Animal Antibiotics & Antimicrobials Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Animal Antibiotics & Antimicrobials Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Animal Antibiotics & Antimicrobials Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Animal Antibiotics & Antimicrobials Market

A detailed market share analysis in the Animal Antibiotics & Antimicrobials Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Animal Antibiotics & Antimicrobials Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Animal Antibiotics & Antimicrobials Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Animal Antibiotics & Antimicrobials Market

A strategic analysis of the Animal Antibiotics & Antimicrobials Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Animal Antibiotics & Antimicrobials Market, highlighting leading vendors and their innovative profiles. These include American Regent Inc., Ayurvet, Bayer AG, Boehringer Ingelheim GmbH, Ceva Sante Animale, Chanelle Pharma, Dechra Pharmaceuticals PLC, Eco Animal Health Group PLC, Elanco Animal Health Incorporated, Eli Lilly and Company, Endovac Animal Health, LLC, Hester Biosciences Limited, Hipra Laboratories, S.A., Inovet Group, Neogen Corporation, Norbrook Laboratories Ltd., Novartis AG, Phibro Animal Health Corporation, Sanofi-Aventis Groupe S.A., Tianjin Ringpu Biotechnology Co., Ltd., Vetoquinol S.A., Virbac S.A., Zoetis, Inc., and Zydus Pharmaceuticals, Inc..

Market Segmentation & Coverage

This research report categorizes the Animal Antibiotics & Antimicrobials Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Antibiotics and Antimicrobial.
  • Based on Mode of Delivery, market is studied across Injections and Oral.
  • Based on Form, market is studied across Powders & Tablets and Solutions.
  • Based on Type of Animal, market is studied across Companion Animals and Food-Producing Animals. The Companion Animals is further studied across Cats, Dogs, and Horses. The Food-Producing Animals is further studied across Cattle, Pigs, Poultry, and Sheep & Goats.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising demand for livestock products and strong demand for penicillin based antibiotics
      • 5.1.1.2. Increasing government involvement in countering animal diseases outbreaks
      • 5.1.1.3. Growing huge capital investment for the development of drugs for animal diseases
    • 5.1.2. Restraints
      • 5.1.2.1. Concerns regarding resistance to antibiotic stringent regulatory approvals
    • 5.1.3. Opportunities
      • 5.1.3.1. Accelerating advanced research and development facilities, and new drug development activities
      • 5.1.3.2. Growing focus towards sustainability of new antimicrobials
    • 5.1.4. Challenges
      • 5.1.4.1. Availability of substitutes
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Growing need for antibiotics for disease prevention and treatment
    • 5.2.2. Mode of Delivery: Rising inclination towards oral administration as it's a non-invasive procedure
    • 5.2.3. Form: Increasing usage of antimicrobial solutions for treating individual animals with severe bacterial infections
    • 5.2.4. Type of Animal: Expanding need for antibiotics & antimicrobials among companion animals to manage bacterial infections
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Animal Antibiotics & Antimicrobials Market, by Product

  • 6.1. Introduction
  • 6.2. Antibiotics
  • 6.3. Antimicrobial

7. Animal Antibiotics & Antimicrobials Market, by Mode of Delivery

  • 7.1. Introduction
  • 7.2. Injections
  • 7.3. Oral

8. Animal Antibiotics & Antimicrobials Market, by Form

  • 8.1. Introduction
  • 8.2. Powders & Tablets
  • 8.3. Solutions

9. Animal Antibiotics & Antimicrobials Market, by Type of Animal

  • 9.1. Introduction
  • 9.2. Companion Animals
    • 9.2.1. Cats
    • 9.2.2. Dogs
    • 9.2.3. Horses
  • 9.3. Food-Producing Animals
    • 9.3.1. Cattle
    • 9.3.2. Pigs
    • 9.3.3. Poultry
    • 9.3.4. Sheep & Goats

10. Americas Animal Antibiotics & Antimicrobials Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Animal Antibiotics & Antimicrobials Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Animal Antibiotics & Antimicrobials Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Zoetis Demonstrates Canine Innovation with Commercial Launch of Librela (bedinvetmab injection) in the U.S.
    • 13.3.2. Huvepharma Returns The Only FDA-Approved Triple-Sulfa Medication To US Market
    • 13.3.3. Elanco and Ginkgo Bioworks Launch BiomEdit, a New Animal Health Company Leveraging Microbiome Technology
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. American Regent Inc.
  • 2. Ayurvet
  • 3. Bayer AG
  • 4. Boehringer Ingelheim GmbH
  • 5. Ceva Sante Animale
  • 6. Chanelle Pharma
  • 7. Dechra Pharmaceuticals PLC
  • 8. Eco Animal Health Group PLC
  • 9. Elanco Animal Health Incorporated
  • 10. Eli Lilly and Company
  • 11. Endovac Animal Health, LLC
  • 12. Hester Biosciences Limited
  • 13. Hipra Laboratories, S.A.
  • 14. Inovet Group
  • 15. Neogen Corporation
  • 16. Norbrook Laboratories Ltd.
  • 17. Novartis AG
  • 18. Phibro Animal Health Corporation
  • 19. Sanofi-Aventis Groupe S.A.
  • 20. Tianjin Ringpu Biotechnology Co., Ltd.
  • 21. Vetoquinol S.A.
  • 22. Virbac S.A.
  • 23. Zoetis, Inc.
  • 24. Zydus Pharmaceuticals, Inc.

LIST OF FIGURES

  • FIGURE 1. ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET RESEARCH PROCESS
  • FIGURE 2. ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET DYNAMICS
  • TABLE 7. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ANTIMICROBIAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY INJECTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY POWDERS & TABLETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY CATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY DOGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY HORSES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY CATTLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PIGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY POULTRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY SHEEP & GOATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 58. MEXICO ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 73. AUSTRALIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. AUSTRALIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 75. AUSTRALIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 76. AUSTRALIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 78. AUSTRALIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 79. CHINA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. CHINA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 81. CHINA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 82. CHINA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 83. CHINA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 84. CHINA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 85. INDIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. INDIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 87. INDIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 88. INDIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 89. INDIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 90. INDIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 91. INDONESIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. INDONESIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 93. INDONESIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 94. INDONESIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 95. INDONESIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 96. INDONESIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 97. JAPAN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. JAPAN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 99. JAPAN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 100. JAPAN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 101. JAPAN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 102. JAPAN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 103. MALAYSIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. MALAYSIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 105. MALAYSIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 106. MALAYSIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 107. MALAYSIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 108. MALAYSIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 109. PHILIPPINES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 110. PHILIPPINES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 111. PHILIPPINES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 112. PHILIPPINES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 113. PHILIPPINES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 114. PHILIPPINES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 115. SINGAPORE ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. SINGAPORE ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 117. SINGAPORE ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 118. SINGAPORE ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 119. SINGAPORE ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 120. SINGAPORE ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 121. SOUTH KOREA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. SOUTH KOREA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH KOREA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH KOREA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH KOREA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH KOREA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 127. TAIWAN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. TAIWAN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 129. TAIWAN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 130. TAIWAN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 131. TAIWAN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 132. TAIWAN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 133. THAILAND ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. THAILAND ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 135. THAILAND ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 136. THAILAND ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 137. THAILAND ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 138. THAILAND ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 139. VIETNAM ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. VIETNAM ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 141. VIETNAM ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 142. VIETNAM ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 143. VIETNAM ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 144. VIETNAM ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 152. DENMARK ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 153. DENMARK ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 154. DENMARK ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 155. DENMARK ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 156. DENMARK ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 157. DENMARK ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 158. EGYPT ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 159. EGYPT ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 160. EGYPT ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 161. EGYPT ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 162. EGYPT ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 163. EGYPT ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 164. FINLAND ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 165. FINLAND ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 166. FINLAND ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 167. FINLAND ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 168. FINLAND ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 169. FINLAND ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 170. FRANCE ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 171. FRANCE ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 172. FRANCE ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 173. FRANCE ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 174. FRANCE ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 175. FRANCE ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 176. GERMANY ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 177. GERMANY ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 178. GERMANY ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 179. GERMANY ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 180. GERMANY ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 181. GERMANY ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 182. ISRAEL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 183. ISRAEL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 184. ISRAEL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 185. ISRAEL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 186. ISRAEL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 187. ISRAEL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 188. ITALY ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 189. ITALY ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 190. ITALY ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 191. ITALY ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 192. ITALY ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 193. ITALY ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 194. NETHERLANDS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 195. NETHERLANDS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 196. NETHERLANDS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 197. NETHERLANDS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 198. NETHERLANDS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 199. NETHERLANDS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 200. NIGERIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 201. NIGERIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 202. NIGERIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 203. NIGERIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 204. NIGERIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 205. NIGERIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 206. NORWAY ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 207. NORWAY ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 208. NORWAY ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 209. NORWAY ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 210. NORWAY ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 211. NORWAY ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 212. POLAND ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 213. POLAND ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 214. POLAND ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 215. POLAND ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 216. POLAND ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 217. POLAND ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 218. QATAR ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 219. QATAR ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 220. QATAR ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 221. QATAR ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 222. QATAR ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 223. QATAR ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 224. RUSSIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 225. RUSSIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 226. RUSSIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 227. RUSSIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 228. RUSSIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 229. RUSSIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 230. SAUDI ARABIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 231. SAUDI ARABIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 232. SAUDI ARABIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 233. SAUDI ARABIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 234. SAUDI ARABIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 235. SAUDI ARABIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 236. SOUTH AFRICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 237. SOUTH AFRICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 238. SOUTH AFRICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 239. SOUTH AFRICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 240. SOUTH AFRICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 241. SOUTH AFRICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 242. SPAIN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 243. SPAIN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 244. SPAIN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 245. SPAIN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 246. SPAIN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 247. SPAIN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 248. SWEDEN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 249. SWEDEN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 250. SWEDEN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 251. SWEDEN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 252. SWEDEN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 253. SWEDEN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 254. SWITZERLAND ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 255. SWITZERLAND ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 256. SWITZERLAND ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 257. SWITZERLAND ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 258. SWITZERLAND ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 259. SWITZERLAND ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 260. TURKEY ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 261. TURKEY ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 262. TURKEY ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 263. TURKEY ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 264. TURKEY ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 265. TURKEY ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 266. UNITED ARAB EMIRATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 267. UNITED ARAB EMIRATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 268. UNITED ARAB EMIRATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 269. UNITED ARAB EMIRATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 270. UNITED ARAB EMIRATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 271. UNITED ARAB EMIRATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 272. UNITED KINGDOM ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED KINGDOM ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED KINGDOM ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED KINGDOM ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED KINGDOM ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED KINGDOM ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 278. ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 279. ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET, FPNV POSITIONING MATRIX, 2023